EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Retrospective Comparative Evaluation of One-Year Efficacy and Safety Outcomes of Somatropin and Somatrogon in Children with Growth Hormone Deficiency: A Single-Center Experience

Şervan Özalkak, Amine Aktar Karakaya

Children · 11.11.2026 · 13 (11) · 1557

DOI: 10.3390/children13111557 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Children, online erschienen am 11.11.2026. Verfasst von Şervan Özalkak und 1 weiteren Autor:innen. Die Arbeit nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To compare one-year growth, insulin-like growth factor 1 (IGF-1), anthropometric, and safety outcomes of once-weekly somatrogon and once-daily somatropin in children with isolated growth hormone deficiency (GHD).

Methods

This single-center retrospective cohort included 150 treatment-naïve children (75 per group); treatment was selected by parental preference. Outcomes were analyzed using repeated-measures general linear models and multivariable regression adjusted for baseline age, sex, Tanner stage, peak stimulated GH, and the corresponding baseline value.

Results

Mean height gain was 9.41 ± 1.48 cm with somatrogon and 9.04 ± 1.42 cm with somatropin (p = 0.126). Adjusted differences were not significant for height gain (0.35 cm; 95% CI, −0.12 to 0.82) or height standard deviation score (SDS) change (0.04; 95% CI, −0.06 to 0.15). Weight, weight SDS, body mass index (BMI), and BMI SDS increased more with somatrogon after adjustment (all p ≤ 0.001). Adjusted one-year increases were also greater with somatrogon for IGF-1 (29.3 ng/mL; 95% CI, 8.2–50.4) and IGF-1 SDS (0.34; 95% CI, 0.11–0.58). IGF-1 SDS >+2 occurred in 16.0% versus 4.0% of patients (difference, 12.0 percentage points; 95% CI, 2.3–22.3; p = 0.027); in 9 of the 12 somatrogon-treated patients, samples were obtained

Zitieren

APA

Özalkak, Ş., & Karakaya, A. A. (2026). Retrospective Comparative Evaluation of One-Year Efficacy and Safety Outcomes of Somatropin and Somatrogon in Children with Growth Hormone Deficiency: A Single-Center Experience. Children, 13(11), 1557. https://doi.org/10.3390/children13111557

Vancouver

Özalkak Ş, Karakaya AA. Retrospective Comparative Evaluation of One-Year Efficacy and Safety Outcomes of Somatropin and Somatrogon in Children with Growth Hormone Deficiency: A Single-Center Experience. Children. 2026;13(11):1557. doi:10.3390/children13111557

BibTeX
@article{zalkak2026,
  author = {Özalkak, Şervan and Karakaya, Amine Aktar},
  title = {Retrospective Comparative Evaluation of One-Year Efficacy and Safety Outcomes of Somatropin and Somatrogon in Children with Growth Hormone Deficiency: A Single-Center Experience},
  journal = {Children},
  year = {2026},
  volume = {13},
  number = {11},
  pages = {1557},
  doi = {10.3390/children13111557}
}
Kostenlos starten →